Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieven Annemans

Showing results (11-20 of 261) with videos related to

Pageof 27
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|January 21, 2021
An early health technology assessment of 3D anatomic models in pediatric congenital heart surgery: potential cost-effectiveness and decision uncertaintyPhilip Tack, Ruben Willems, Lieven Annemans
Journal of Medical Economics|January 17, 2013
Cost-effectiveness of dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation in BelgiumHanne Wouters, Vincent Thijs, Lieven Annemans
Journal of Pain and Symptom Management|June 15, 2018
Resource Use During the Last Six Months of Life Among COPD Patients: A Population-Level StudyKristof Faes, Joachim Cohen, Lieven Annemans
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2013
Current methodological issues in the economic assessment of personalized medicineLieven Annemans, Ken Redekop, Katherine Payne
Journal of the American Geriatrics Society|February 16, 2018
Resource Use During the Last 6 Months of Life of Individuals Dying with and of Alzheimer's DiseaseKristof Faes, Joachim Cohen, Lieven Annemans
Critical Reviews in Oncology/Hematology|April 28, 2007
Critical appraisal of scientific posters comparing anemia treatments for cancer patients: applying ISPOR Task Force guidelines on methodological quality of retrospective studiesNadia Demarteau, Karen Moeremans, Lieven Annemans, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 12, 2015
Hurdles that impede economic evaluations of welfare interventionsJanne Schepers, Lieven Annemans, Steven Simoens
American Journal of Hypertension|September 5, 2009
Proteinuria and clinical outcomes in hypertensive patientsAusilia Maione, Lieven Annemans, Giovanni Strippoli
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 29, 2004
Cost-effectiveness analysis of bicalutamide (Casodex) for adjuvant treatment of early prostate cancerKaren Moeremans, Karin Caekelbergh, Lieven Annemans
Psychiatria Danubina|September 3, 2013
The cost of alcohol in the workplace in BelgiumJuan Tecco, Denis Jacques, Lieven Annemans
Pageof 27

Showing results (11-20 of 261) with videos related to

Sort By:
Pageof 27
Expert Review of Pharmacoeconomics & Outcomes Research|January 21, 2021
An early health technology assessment of 3D anatomic models in pediatric congenital heart surgery: potential cost-effectiveness and decision uncertaintyPhilip Tack, Ruben Willems, Lieven Annemans
Journal of Medical Economics|January 17, 2013
Cost-effectiveness of dabigatran etexilate in the prevention of stroke and systemic embolism in patients with atrial fibrillation in BelgiumHanne Wouters, Vincent Thijs, Lieven Annemans
Journal of Pain and Symptom Management|June 15, 2018
Resource Use During the Last Six Months of Life Among COPD Patients: A Population-Level StudyKristof Faes, Joachim Cohen, Lieven Annemans
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 17, 2013
Current methodological issues in the economic assessment of personalized medicineLieven Annemans, Ken Redekop, Katherine Payne
Journal of the American Geriatrics Society|February 16, 2018
Resource Use During the Last 6 Months of Life of Individuals Dying with and of Alzheimer's DiseaseKristof Faes, Joachim Cohen, Lieven Annemans
Critical Reviews in Oncology/Hematology|April 28, 2007
Critical appraisal of scientific posters comparing anemia treatments for cancer patients: applying ISPOR Task Force guidelines on methodological quality of retrospective studiesNadia Demarteau, Karen Moeremans, Lieven Annemans, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 12, 2015
Hurdles that impede economic evaluations of welfare interventionsJanne Schepers, Lieven Annemans, Steven Simoens
American Journal of Hypertension|September 5, 2009
Proteinuria and clinical outcomes in hypertensive patientsAusilia Maione, Lieven Annemans, Giovanni Strippoli
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 29, 2004
Cost-effectiveness analysis of bicalutamide (Casodex) for adjuvant treatment of early prostate cancerKaren Moeremans, Karin Caekelbergh, Lieven Annemans
Psychiatria Danubina|September 3, 2013
The cost of alcohol in the workplace in BelgiumJuan Tecco, Denis Jacques, Lieven Annemans
Pageof 27